| |
|
|
|
|
|
| Country or region |
Year |
Number tested |
% infected (1) |
Setting/comments (2) (3) |
References |
| |
|
|
|
|
|
| Belgium |
2001-02 |
1 651 |
0.0-(6.2) |
Drug treatment centres, needle exchange; screening serum and self-reported test results |
1, 2, 6, 8 |
| Czech Republic |
2002 |
3773 |
0.0-(1.3) |
Drug treatment centres, needle exchanges, low threshold services, STD clinics, other hospital or clinics, HIV testing centres; screening serum |
1 |
| Denmark |
1996-97 |
608 |
(0.0-3.4) |
Funen: study prison/ drug treatment; Copenhagen: drug treatment, self-reported test results |
1, 2 |
| Germany |
2000-01 |
2 575 |
2.8-4.0 |
Drug treatment reporting system; drug overdose deaths |
1, 3, 17 |
| Estonia |
2001-02 |
4 228 |
6.2-(41) |
Drug treatment centres, needle exchanges, public health laboratories, general practitioners, STD clinics, other hospital or clinics, antenatal clinics, HIV testing centres; screening serum |
1, 2 |
| Greece |
2002 |
3 207 |
(0.0-3.3) |
Drug treatment centres, low-threshold services, public health laboratories/STD clinics/HIV testing centres; screening serum |
1, 2, 9 |
| Spain |
2001-02 |
7 680 |
9.7-34.7 |
Drug treatment centres, HIV testing centres, STI clinics; screening serum |
1, 2, 28 |
| France |
2002 |
358 |
(13.7) |
Needle exchanges, low-threshold services in 12 cities; self-reported test results |
4 |
| Ireland |
1998-99 |
682 |
3.5 -5.8 |
Prisons: screening saliva |
2, 4 |
| Italy |
2002 |
70 075 |
14.7 (0.6-32.6) |
Drug treatment in public services (total and range of regional prevalences); potential underestimation due to inclusion of unknown but probably small proportions of non-IDUs |
1 |
| Cyprus |
not avail. |
|
|
|
|
| Latvia |
2002-03 |
2805 |
6.6-(22.0) |
Drug treatment centres, hospital or clinics, arrests, needle exchanges, street, HIV councelling centre; screening serum |
1, 4, 5 |
| Lithuania |
2003 |
1347 |
(0.4)-2.4 |
Drug treatment centres, needle exchange, hospitals |
1, 3 |
| Luxembourg |
2002 |
245 |
4.1 |
Drug treatment, low threshold services, hospitals, police; self-reported test results |
1 |
| Hungary |
2001 |
315 |
0 |
Drug treatment centres |
1 |
| Malta |
not avail. |
|
|
|
|
| Netherlands |
1998-02 |
1 595 |
(0.5-25.9) |
Surveys in and outside drug treatment: Amsterdam, Brabant region, Groningen, Rotteram, South-Limburg region, The Hague, Twente region; screening saliva |
1, 3, 4, 6, 8, 9, 21 |
| Austria |
2002 |
396 |
(0.0)-4.0 |
Opiate overdose deaths, emergencies, drug treatment centres, low threshold services, needle exchange; screening serum |
1, 2, 3, 4 |
| Poland |
2002 |
2791 |
6.8-(29.7) |
Public health laboratories, HIV testing centres, drug treatment centres, STI clinics, street; screening serum |
1, 2 |
| Portugal |
2000-02 |
394 / 8382 |
(9.4-41.3) / 10.8-16.0 |
Drug treatment centres; screening serum. National data include unknown proportion of non-IDUs and may underestimate prevalence in IDUs |
1, 2, 6, 7 |
| Slovenia |
2002-03 |
515 |
(0.0) |
Drug treatment centres, needle exchanges; self-reported test results and screening saliva |
1 |
| Slovakia |
2002-03 |
1 961 |
(0.0) |
Drug treatment centres; screening serum. |
2, 3 |
| Finland |
2002 |
523 |
(0.0-1.0) |
Needle exchanges; screening saliva or serum |
1, 8 |
| Sweden |
1997 |
196 |
2.6 |
Study in nine prisons |
1 |
| UK |
2000-01 |
7171 |
0.3-(4.5) |
Drug treatment centres, needle exchange, low threshold, primary care and outreach, named HIV tests; screening saliva and serum |
1, 5 |
| Norway |
2002 |
410 |
(1.2) |
Needle exchange; screening serum |
2 |
| |
|
|
|
|
|
| |
|
|
|
|
|
| Notes: |
|
|
|
|
|
| This summary table intends to give a global overview of HIV prevalence in IDUs in the EU. In this table data are reported for the most recent year available. Data from samples of drug users with no information on injecting status were excluded. Data sources for more than one year are used if they clearly improve generalisability (e.g. national data, out-of-treatment data). Prevalence in this table should not be compared with previous versions to follow changes over time, as inclusion of sources may vary according to data availability. For time trends see [the annex of this statistical bulletin]. |
|
| (1) The figures given in brackets show local estimates (or range of estimates) within the country. |
|
| (2) Self-reported test results are less reliable than biological test results. |
|
| (3) Having health problems is one selection criterion for admission to drug treatment in some countries or cities (Greece, Portugal, Rome), due to long waiting lists or special programmes for infected IDUs, and this may result in upward bias of prevalence. Prevalence from treatment data should therefore be interpreted in combination with non-treatment data. |
|
| |
|
|
|
|
|
| Sources: |
|
|
|
|
|
| See [Table IDisease-0 Part (i)] |
|
| |
|
|
|
|
|
